Polymorphisms of pro-inflammatory genes and Alzheimer’s disease risk: A pharmacogenomic approach

Calogero Caruso, Sonya Vasto, Domenico Lio, Carmela Rita Balistreri, Giuseppina Colonna Romano, Giuseppina Candore, Martina Chiappelli, Federico Licastro, Florinda Listi', Maria Paola Grimaldi

Risultato della ricerca: Articlepeer review

42 Citazioni (Scopus)


Clinically and pathologically Alzheimer’s disease (AD) represents a sequential progressive neurodegenerative disorder. AD is etiologically heterogeneous and accounts for a majority of dementia in western societies. Inflammation clearly occurs in pathologically vulnerable regions of the AD brain and the search for genetic factors influencing the pathogenesis of AD has lead to the identification of numerous gene polymorphisms that might act as susceptibility modifiers. Accordingly, several reports have indicated that the risk of AD is substantially influenced by several genetic polymorphisms in the promoter region, or other untranslated regions, of genes encoding inflammatory mediators, although not all the studies were replied. Here, we review several data suggesting that inflammatory genetic variation may contribute to AD susceptibility. All together this information may represent the basis both for future recognition of individuals at risk and for the pharmacogenomic driving of drug responsiveness.
Lingua originaleEnglish
pagine (da-a)67-75
Numero di pagine9
RivistaMechanisms of Ageing and Development
Stato di pubblicazionePublished - 2007

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.1300.1302???
  • ???subjectarea.asjc.1300.1309???


Entra nei temi di ricerca di 'Polymorphisms of pro-inflammatory genes and Alzheimer’s disease risk: A pharmacogenomic approach'. Insieme formano una fingerprint unica.

Cita questo